CHALLENGES OF PATIENTS WITH PACEMAKER FOR IPSILATERAL BREAST CONSERVING SURGERY FOR CARCINOMA BREAST – A CASE SERIES

Mapping Intimacies ◽

10.36106/ijsr/5729328 ◽

2021 ◽

pp. 30-31

Author(s):

Anita Kulkarni ◽

Soumi Pathak

Keyword(s):

Cancer Treatment ◽

Case Series ◽

Breast Conserving Surgery ◽

Ipsilateral Breast ◽

Carcinoma Breast ◽

Rhythm Disorder

Pacemakers, implanted cardiac debrillators and ventricular assisted devices are frequently used for managing heart failures and patients with rhythm disorder. While managing such patients coming for oncosurgeries and cancer treatment, there are several issues related to equipment characteristic whose understanding is a must for the anaesthesiologist. There is a possibility of malfunctioning of these devices, however timely intervention can prevent catastrophic outcomes.

Download Full-text

Breast conserving surgery versus salvage mastectomy for ipsilateral breast cancer recurrence: a propensity score matching analysis

Updates in Surgery ◽

10.1007/s13304-021-01122-3 ◽

2021 ◽

Author(s):

Damiano Gentile ◽

Andrea Sagona ◽

Erika Barbieri ◽

Lidija Antunovic ◽

Davide Franceschini ◽

...

Keyword(s):

Breast Cancer ◽

Propensity Score ◽

Propensity Score Matching ◽

Cancer Recurrence ◽

Breast Conserving Surgery ◽

Breast Cancer Recurrence ◽

Ipsilateral Breast ◽

Propensity Score Matching Analysis ◽

Salvage Mastectomy

Download Full-text

Invited commentary: Outcomes from ipsilateral breast tumor recurrence after breast conserving surgery and whole breast irradiation for breast cancer

The American Journal of Surgery ◽

10.1016/j.amjsurg.2021.08.001 ◽

2021 ◽

Author(s):

Stephen F. Sener

Keyword(s):

Breast Cancer ◽

Breast Tumor ◽

Tumor Recurrence ◽

Ipsilateral Breast Tumor Recurrence ◽

Breast Conserving Surgery ◽

Whole Breast Irradiation ◽

Breast Irradiation ◽

Ipsilateral Breast

Download Full-text

Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up

Clinics ◽

10.6061/clinics/2017(03)02 ◽

2017 ◽

Vol 72 (3) ◽

pp. 134-142 ◽

Cited By ~ 7

Author(s):

GF Carrara ◽

C Scapulatempo-Neto ◽

LF Abrahão-Machado ◽

MM Brentani ◽

JS Nunes ◽

...

Keyword(s):

Breast Tumor ◽

Tumor Recurrence ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Ipsilateral Breast Tumor Recurrence ◽

Breast Conserving Surgery ◽

Ipsilateral Breast ◽

Long Term Follow Up

Download Full-text

Cases of cytomegalovirus retinitis in patients treated for cancer

Malaysian Journal of Ophthalmology ◽

10.35119/myjo.v2i1.96 ◽

2020 ◽

Vol 2 (1) ◽

pp. 69-74

Author(s):

Marium Jamaluddin Ahmad ◽

Tengku Ain Kamalden ◽

Nurliza Khaliddin ◽

Tajunisah Iqbal

Keyword(s):

Cancer Treatment ◽

Opportunistic Infection ◽

Case Series ◽

Cytomegalovirus Retinitis ◽

Immunocompromised Patients ◽

Blurred Vision ◽

Cmv Retinitis ◽

Frosted Branch Angiitis

Cytomegalovirus (CMV) retinitis is an opportunistic infection affecting immunocompromised patients. This case series describes 2 patients aged 19 and 10 years who were undergoing cancer treatment and were referred for complaints of worsening blurred vision. The retinal findings in the first patient showed multiple yellowishsubretinal areas with haemorrhages, while in the second patient there was presence of frosted branch angiitis. Confirmation of diagnosis was done using PCR of vitreous samples and blood CMV levels. Both tested negative for HIV. Both received intravitreal and systemic ganciclovir. It is important for ophthalmologists to consider CMVretinitis in all patients with any form of immunosuppression.

Download Full-text

Tumors associated with radiotherapy: a case series

Journal of Medical Case Reports ◽

10.1186/s13256-020-02482-x ◽

2020 ◽

Vol 14 (1) ◽

Author(s):

Mauricio Garcia ◽

Dary L. Hernandez ◽

Sara Mendoza ◽

Nelson Buelvas ◽

Angelina Alvarez ◽

...

Keyword(s):

Breast Cancer ◽

Basal Cell Carcinoma ◽

Cancer Treatment ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Case Series ◽

Breast Cancer Treatment ◽

Induced Tumors ◽

Incidence And Mortality

Abstract Background Breast cancer is the cancer with the highest incidence and mortality worldwide. Its treatment is multidisciplinary with surgery, systemic therapy, and radiotherapy. In Colombia, according to Globocan 2018, there is an age-standardized incidence rate of 44 per 100,000 women. Radiotherapy improves local and regional control in patients with breast cancer, and it could even improve relapse-free survival and overall survival in patients with nodal disease. The toxicity of this treatment in most cases is mild and transient, but in a low percentage of patients, radiotherapy-induced tumors may develop. Case presentation Seven Colombian patients treated for breast cancer at our institution developed radiotherapy-induced tumors between 2008 and 2018. The median age was 54.4 (range 35–72) years. Six patients had locally advanced tumors at the time breast cancer was diagnosed, and all of them received neoadjuvant or adjuvant chemotherapy and radiotherapy. The radiotherapy-induced tumors were five sarcomas, one of which was a well-differentiated angiosarcomatous vascular lesion with negative c-Myc (benign lesion), and the remaining patient had basal cell carcinoma associated with radiotherapy. Conclusions Sarcomas are the most common radiotherapy-induced tumors after breast cancer treatment. These are rare, aggressive tumors and represent between 0.5% and 5.5% of all sarcomas. Basal cell carcinoma has also been associated with breast cancer treatment. The management is individualized and multimodal, including surgical resection and chemotherapy. Different studies have shown that radiation therapy is a risk factor for the development of soft tissue tumors.

Download Full-text

The impact of decision aids in patients with colorectal cancer: a systematic review

BMJ Open ◽

10.1136/bmjopen-2018-028379 ◽

2019 ◽

Vol 9 (9) ◽

pp. e028379 ◽

Cited By ~ 4

Author(s):

Jenaya Goldwag ◽

Priscilla Marsicovetere ◽

Peter Scalia ◽

Heather A Johnson ◽

Marie-Anne Durand ◽

...

Keyword(s):

Colorectal Cancer ◽

Systematic Review ◽

Cancer Treatment ◽

Data Extraction ◽

Decision Aids ◽

Case Series ◽

Cochrane Library ◽

Eligibility Criteria ◽

The Impact ◽

Colorectal Cancer Treatment

ObjectivesOur aim was to conduct a systematic review of the literature to determine the impact of patient decision aids (PDA) on patients facing treatment decisions for colorectal cancer.DesignSystematic review.Data sourcesSources included Embase, Medline, Web of Science, CINAHL and the Cochrane Library from inception to June, 20, 2019.Eligibility criteriaWe included randomised controlled trials (RCTs), cohort studies, mixed methods and case series in which a PDA for colorectal cancer treatment was used. Qualitative studies were excluded from our review.Data extraction and synthesisFollowing execution of the search strategy by a medical librarian, two blinded independent reviewers identified articles for inclusion. Two blinded reviewers were also responsible for data extraction, risk of bias and study quality assessments. Any conflict in article inclusion or extraction was resolved by discussion.ResultsOut of 3773 articles identified, three met our inclusion criteria: one RCT, one before-and-after study and one mixed-method study. In these studies, the use of a PDA for colorectal cancer treatment was associated with increased patient knowledge, satisfaction and preparation for making a decision. On quality assessment, two of three studies were judged to be of low quality.ConclusionA paucity of evidence exists on the effect of PDA for colorectal cancer treatment with existing evidence being largely of low quality. Further investigation is required to determine the effect of decision aids for colorectal cancer treatment as well as reasons for the lack of PDA development and implementation in this area.Prospero registration numberCRD42018095153.

Download Full-text